Table 5.
Prevalence of the population with raised blood glucose or on medication for blood glucose disaggregated by diagnosis and treatment status
| Category | On medication and glucose < 7 mmol/L | On medication and glucose ≥ 7 mmol/L | Not aware of raised glucose ≥ 7 mmol/L | Not taking prescribed medication and glucose ≥ 7 mmol/L | Total N |
|---|---|---|---|---|---|
| Age group | |||||
| 18–29 | 12.0 (0.7–2.3) | 10.3 (6.9–15.1) | 39.2 (34.3–44.3) | 49.2 (43.9–54.6) | 87 |
| 30–39 | 6.6 (4.9–8.9) | 6.5 (4.9–8.5) | 29.1 (25.9–32.3) | 57.8 (54.2–61.4) | 215 |
| 40–49 | 12.1 (10.3–14.2) | 10.1 (8.3–12.1) | 16.7 (14.4–19.2) | 61.1 (57.0–65.0) | 259 |
| 50–59 | 25.3 (21.8–29.1) | 11.3 (9.5–13.4) | 8.8 (7.5–10.3) | 54.6 (50.4–58.8) | 236 |
| 60+ | 14.2 (12.0–16.5) | 23.3 (19.9–27.1) | 12.8 (10.8–15.0) | 49.8 (45.2–54.4) | 226 |
| Sex | |||||
| Male | 13.0 (11.5–14.8) | 10.4 (8.9–12.2) | 20.8 (19–22.7) | 55.7 (52.6–58.7) | 526 |
| Female | 15.7 (13.9–17.6) | 16.0 (14.2–18) | 13.0 (11.5–14.6) | 55.3 (25.5–58.1) | 497 |
| Nationality | |||||
| Omani | 15.3 (13.8–17.0) | 14.9 (13.3–16.6) | 13.4 (12.1–14.7) | 56.5 (53.7–59.1) | 683 |
| Non-Omani | 12.3 (10.4–14.5) | 9.7 (7.9–11.7) | 24.5 (22.2–26.8) | 53.6 (50.6–56.6) | 340 |
| Overall | 14.3 (13.1–15.6) | 13.2 (12–14.5) | 17.0 (15.9–18.2) | 55.5 (53.4–57.6) | 1023 |